ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006

DCPC Bard Approves Concepts For New Grant Programs

November 13, 1992

NIH Makes Changes To Area Grants

April 25, 1997

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973